Who is sponsoring Sugammadex?

Sugammadex is sponsored by University Health Network, Toronto.

What condition does Sugammadex study?

Sugammadex studies Obstructive Sleep Apnea.

What drugs are being tested in Sugammadex?

Interventions: Sugammadex Sodium, Neostigmine.

What is the status of Sugammadex?

Sugammadex is currently COMPLETED.

Last reviewed 2025-03-20 · How we verify

Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications

NCT03679611 PHASE4 COMPLETED Results posted

Sugammadex or neostigmine are given at the end of the surgery to reverse neuro muscular blocking drugs (NMBD). This study will evaluate whether reversal of NMBD with sugammadex is associated with faster recovery than neostigmine resulting in faster discharge from the operating room (OR) in obese patients with OSA undergoing bariatric surgery. Half of the patients in the study will receive sugammadex and the other half of the patients will receive neostigmine.

Details

Lead sponsor	University Health Network, Toronto
Phase	PHASE4
Status	COMPLETED
Enrolment	120
Start date	Mon Jan 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Obstructive Sleep Apnea

Interventions

Sugammadex Sodium
Neostigmine

Countries

Canada